Cellectis S.A. 13D and 13G filings for Calyxt, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-01 2:46 pm Purchase | 2023-05-31 | 13D | Calyxt, Inc. CLXT | Cellectis S.A. | 479,264 2.900% | 0 (+0.00%) | Filing |
| 2023-01-17 4:08 pm Unchanged | 2023-01-13 | 13D | Calyxt, Inc. CLXT | Cellectis S.A. | 479,264 49.100% | 0 (Unchanged) | Filing |
| 2022-11-01 4:30 pm Unchanged | 2022-10-31 | 13D | Calyxt, Inc. CLXT | Cellectis S.A. | 479,264 49.100% | 0 (Unchanged) | Filing |
| 2020-10-23 4:01 pm Purchase | 2020-10-16 | 13D | Calyxt, Inc. CLXT | Cellectis S.A. | 479,264 64.700% | 25,000 (+5.50%) | Filing |
| 2020-07-10 08:45 am Unchanged | 2020-07-06 | 13D | Calyxt, Inc. CLXT | Cellectis S.A. | 454,264 68.700% | 0 (Unchanged) | Filing |